Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brook B Cole

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Tissue Engineering|April 10, 2007
Chondrogenic differentiation potential of human mesenchymal stem cells photoencapsulated within poly(ethylene glycol)-arginine-glycine-aspartic acid-serine thiol-methacrylate mixed-mode networksChelsea N Salinas, Brook B Cole, Andrea M Kasko, et al.
The American Journal of Pathology|June 5, 2010
Tracheal Basal cells: a facultative progenitor cell poolBrook B Cole, Russell W Smith, Kimberly M Jenkins, et al.
The American Journal of Pathology|June 28, 2011
β-catenin dosage is a critical determinant of tracheal basal cell fate determinationHeather M Brechbuhl, Moumita Ghosh, Mary Kathryn Smith, et al.
BMC Cancer|November 3, 2011
The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancerTobias Hahn, Deborah J Bradley-Dunlop, Laurence H Hurley, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Tissue Engineering|April 10, 2007
Chondrogenic differentiation potential of human mesenchymal stem cells photoencapsulated within poly(ethylene glycol)-arginine-glycine-aspartic acid-serine thiol-methacrylate mixed-mode networksChelsea N Salinas, Brook B Cole, Andrea M Kasko, et al.
The American Journal of Pathology|June 5, 2010
Tracheal Basal cells: a facultative progenitor cell poolBrook B Cole, Russell W Smith, Kimberly M Jenkins, et al.
The American Journal of Pathology|June 28, 2011
β-catenin dosage is a critical determinant of tracheal basal cell fate determinationHeather M Brechbuhl, Moumita Ghosh, Mary Kathryn Smith, et al.
BMC Cancer|November 3, 2011
The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancerTobias Hahn, Deborah J Bradley-Dunlop, Laurence H Hurley, et al.
Pageof 1